ArticleCells2022

Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas.

Manon Penco-Campillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.